Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Sarcoma 180

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Sarcoma 180 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braquet, P; Ishii, S; Karasawa, K; Nojima, S; Nozaki, T; Oda, K; Sasaki, T; Satoh, N; Senda, M; Setaka, M; Tohyama, T; Toyama, H1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Sarcoma 180

ArticleYear
A distribution study of 11C platelet-activating factor (PAF) analogs in normal and tumor-bearing mice.
    Nuclear medicine and biology, 1996, Volume: 23, Issue:3

    Topics: Animals; Carbon Radioisotopes; Kinetics; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reference Values; Sarcoma 180; Stereoisomerism; Tissue Distribution

1996